Citation: Zj. Zhang et al., GENETIC-ANALYSIS OF THE U5-PBS OF A NOVEL HIV-1 REVEALS MULTIPLE INTERACTIONS BETWEEN THE TRANSFER-RNA AND RNA GENOME REQUIRED FOR INITIATION OF REVERSE TRANSCRIPTION, RNA, 4(4), 1998, pp. 394-406
Authors:
BASAK S
MCPHERSON S
KANG S
COLLAWN JF
MORROW CD
Citation: S. Basak et al., CONSTRUCTION AND CHARACTERIZATION OF ENCAPSIDATED POLIOVIRUS REPLICONS THAT EXPRESS BIOLOGICALLY-ACTIVE MURINE INTERLEUKIN-2, Journal of interferon & cytokine research, 18(5), 1998, pp. 305-313
Citation: Zj. Zhang et al., GENETIC-EVIDENCE OF THE INTERACTION BETWEEN TRNA(LYS,3) AND U5 FACILITATING EFFICIENT INITIATION OF REVERSE TRANSCRIPTION BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, AIDS research and human retroviruses, 14(11), 1998, pp. 979-988
Authors:
PORTER DC
ANSARDI DC
WANG J
MCPHERSON S
MOLDOVEANU Z
MORROW CD
Citation: Dc. Porter et al., DEMONSTRATION OF THE SPECIFICITY OF POLIOVIRUS ENCAPSIDATION USING A NOVEL REPLICON WHICH ENCODES ENZYMATICALLY ACTIVE FIREFLY LUCIFERASE, Virology, 243(1), 1998, pp. 1-11
Authors:
ZHANG ZJ
YU Q
KANG SM
BUESCHER J
MORROW CD
Citation: Zj. Zhang et al., PREFERENTIAL COMPLETION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRUSES INITIATED WITH TRNA(3)(LYS) RATHER THAN TRNA(1,2)(LYS), Journal of virology, 72(7), 1998, pp. 5464-5471
Citation: Y. Li et al., STABILITY OF HIV TYPE-1 PROVIRAL GENOMES THAT CONTAIN 2 DISTINCT PRIMER-BINDING SITES, AIDS research and human retroviruses, 13(3), 1997, pp. 253-262
Authors:
ANDERSON MJ
PORTER DC
MOLDOVEANU Z
FLETCHER TM
MCPHERSON S
MORROW CD
Citation: Mj. Anderson et al., CHARACTERIZATION OF THE EXPRESSION AND IMMUNOGENICITY OF POLIOVIRUS REPLICONS THAT ENCODE SIMIAN IMMUNODEFICIENCY VIRUS SIV(MAC)239 GAG OR ENVELOPE SU PROTEINS, AIDS research and human retroviruses, 13(1), 1997, pp. 53-62
Authors:
PORTER DC
WANG J
MOLDOVEANU Z
MCPHERSON S
MORROW CD
Citation: Dc. Porter et al., IMMUNIZATION OF MICE WITH POLIOVIRUS REPLICONS EXPRESSING THE C-FRAGMENT OF TETANUS TOXIN PROTECTS AGAINST LETHAL CHALLENGE WITH TETANUS TOXIN, Vaccine, 15(3), 1997, pp. 257-264
Authors:
MESTECKY J
MOLDOVEANU Z
MICHALEK SM
MORROW CD
COMPANS RW
SCHAFER DP
RUSSELL MW
Citation: J. Mestecky et al., CURRENT OPTIONS FOR VACCINE DELIVERY SYSTEMS BY MUCOSAL ROUTES, Journal of controlled release, 48(2-3), 1997, pp. 243-257
Authors:
LI Y
ZHANG ZJ
KANG SM
BUESCHER JL
MORROW CD
Citation: Y. Li et al., INSIGHTS INTO THE INTERACTION BETWEEN TRANSFER-RNA AND PRIMER BINDING-SITE FROM CHARACTERIZATION OF A UNIQUE HIV-1 VIRUS WHICH STABLY MAINTAINS DUAL PBS COMPLEMENTARY TO TRNA(GLY) AND TRNA(HIS), Virology, 238(2), 1997, pp. 273-282
Authors:
LI Y
ZHANG ZJ
WAKEFIELD JK
KANG SM
MORROW CD
Citation: Y. Li et al., NUCLEOTIDE SUBSTITUTIONS WITHIN U5 ARE CRITICAL FOR EFFICIENT REVERSETRANSCRIPTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH A PRIMER BINDING-SITE COMPLEMENTARY TO TRNA(HIS), Journal of virology, 71(9), 1997, pp. 6315-6322
Citation: Sm. Kang et al., IDENTIFICATION OF A SEQUENCE WITHIN U5 REQUIRED FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO STABLY MAINTAIN A PRIMER BINDING-SITE COMPLEMENTARY TO TRNA(MET), Journal of virology, 71(1), 1997, pp. 207-217
Authors:
ZHANG ZJ
KANG SM
LEBLANC A
HAJDUK SL
MORROW CD
Citation: Zj. Zhang et al., NUCLEOTIDE-SEQUENCES WITHIN THE U5 REGION OF THE VIRAL-RNA GENOME ARETHE MAJOR DETERMINANTS FOR AN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO MAINTAIN A PRIMER BINDING-SITE COMPLEMENTARY TO TRNA(HIS), Virology, 226(2), 1996, pp. 306-317
Citation: Sm. Kang et al., MUTATIONS IN BOTH THE U5 REGION AND THE PRIMER-BINDING SITE INFLUENCETHE SELECTION OF THE TRANSFER-RNA USED FOR THE INITIATION OF HIV-1 REVERSE TRANSCRIPTION, Virology, 222(2), 1996, pp. 401-414
Citation: Jk. Wakefield et Cd. Morrow, MUTATIONS WITHIN THE PRIMER BINDING-SITE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DEFINE SEQUENCE REQUIREMENTS ESSENTIAL FOR REVERSE TRANSCRIPTION, Virology, 220(2), 1996, pp. 290-298
Citation: Mj. Anderson et al., POLIOVIRUS REPLICONS THAT EXPRESS THE GAG OR THE ENVELOPE SURFACE PROTEIN OF SIMIAN IMMUNODEFICIENCY VIRUS SIVSMM PBJ14, Virology, 219(1), 1996, pp. 140-149
Authors:
QUAN YD
GU ZX
LI XG
LI Z
MORROW CD
WAINBERG MA
Citation: Yd. Quan et al., ENDOGENOUS REVERSE TRANSCRIPTION ASSAYS REVEAL HIGH-LEVEL RESISTANCE TO THE TRIPHOSPHATE OF (-)2'-DIDEOXY-3'-THIACYTIDINE BY MUTATED M184V HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology, 70(8), 1996, pp. 5642-5645
Citation: Dc. Porter et al., RELEASE OF VIRUS-LIKE PARTICLES FROM CELLS INFECTED WITH POLIOVIRUS REPLICONS WHICH EXPRESS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG, Journal of virology, 70(4), 1996, pp. 2643-2649
Citation: Jk. Wakefield et al., CONSTRUCTION OF A TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS THAT MAINTAINS A PRIMER BINDING-SITE COMPLEMENTARY TO TRNA(HIS), Journal of virology, 70(2), 1996, pp. 966-975
Authors:
WILSON JE
AULABAUGH A
CALIGAN B
MCPHERSON S
WAKEFIELD JK
JABLONSKI S
MORROW CD
REARDON JE
FURMAN PA
Citation: Je. Wilson et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - CONTRIBUTION OF MET-184 TO BINDING OF NUCLEOSIDE 5'-TRIPHOSPHATE, The Journal of biological chemistry, 271(23), 1996, pp. 13656-13662
Authors:
MOLDOVEANU Z
PORTER DC
MCPHEARSON S
MESTECKY J
MORROW CD
Citation: Z. Moldoveanu et al., IMMUNE-RESPONSES INDUCED BY ADMINISTRATION OF ENCAPSIDATED POLIOVIRUSREPLICONS WHICH EXPRESS HIV-1 GAG AND ENV PROTEINS, The FASEB journal, 9(3), 1995, pp. 214-214
Authors:
MOLDOVEANU Z
PORTER DC
LU AL
MCPHERSON S
MORROW CD
Citation: Z. Moldoveanu et al., IMMUNE-RESPONSES INDUCED BY ADMINISTRATION OF ENCAPSIDATED POLIOVIRUSREPLICONS WHICH EXPRESS HIV-1 GAG AND ENVELOPE PROTEINS, Vaccine, 13(11), 1995, pp. 1013-1022
Citation: Sa. Jablonski et Cd. Morrow, MUTATION OF THE ASPARTIC-ACID RESIDUES OF THE GDD SEQUENCE MOTIF OF POLIOVIRUS RNA-DEPENDENT RNA-POLYMERASE RESULTS IN ENZYMES WITH ALTEREDMETAL-ION REQUIREMENTS FOR ACTIVITY, Journal of virology, 69(3), 1995, pp. 1532-1539
Citation: Dc. Ansardi et Cd. Morrow, AMINO-ACID SUBSTITUTIONS IN THE POLIOVIRUS MATURATION CLEAVAGE SITE AFFECT ASSEMBLY AND RESULT IN ACCUMULATION OF PROVIRIONS, Journal of virology, 69(3), 1995, pp. 1540-1547